Re-Entering Antibacterial Discovery and Development Summit

25-28 September 2018
Boston, USA

Cambridge Healthtech Institute’s 5th Annual Re-Entering Antibacterial Discovery and Development Summit features two conferences: Antibacterial Discovery and Development (September 26-27), and Targeting Gram-Negative Pathogens (September 27-28).

 

Session

Funders and accelerators

Date: Thursday, 27 September 2018
Time: 9:05

 

Panel Discussion

Filling in the Funding Gaps

Date: Thursday, 27 September 2018
Time: 10:20

Moderator: Vikas Goyal, Associate, SR One

Speakers:

  • Mark Albrecht, Acting Branch Chief, Antibacterials Program, Biomedical Advanced Research and Development Authority, USA
  • Kevin Outterson, Professor of Law, Boston University; Executive Director, CARB-X
  • Aleks Engel, Partner, Novo Seeds, Nova Holdings, Danmark
  • François Franceschi, Project Leader AMREP, GARDP, Switzerland

 

 

More information: